LSL Pharma Group Inc Class A LSL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$0.30
- Day Range
- CA$0.29–0.30
- 52-Week Range
- CA$0.28–0.55
- Bid/Ask
- CA$0.29 / CA$0.30
- Shares Outstanding
- 126.73M
- Market Cap
- CA$36.75M
- Volume/Avg
- 14,750 / 37,502
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.85
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
LSL Pharma Group Inc develops, manufactures and commercializes sterile pharmaceutical products, cosmetic products and natural health products. It operates in three segments CMO activities include four operating entities LSL Laboratory, Dermolab, Du-Var, and VSI; Integrated Eye-care pharmaceutical company which includes sterile Eye-care manufacturing operation; and Private Label Business includes Juno OTC which commercializes pharmaceutical products with a focus on private label, over the counter (OTC) products. It derives majority of revenue from CMO activities segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 245
- Website
- https://www.groupelslpharma.com
Valuation
|
Metric
|
LSL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.72 |
Price/Sales | 0.85 |
Price/Cash Flow | — |
Price/Earnings
LSL
Financial Strength
|
Metric
|
LSL
|
|---|---|
Quick Ratio | 0.37 |
Current Ratio | 1.16 |
Interest Coverage | −1.10 |
Quick Ratio
LSL
Profitability
|
Metric
|
LSL
|
|---|---|
Return on Assets (Normalized) | −13.03% |
Return on Equity (Normalized) | −39.25% |
Return on Invested Capital (Normalized) | −9.54% |
Return on Assets
LSL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|#B$##$mV | LOCK|d?^N | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|$%Yy$<# | LOCK|^%#% | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|fq$?>>s | LOCK|N<# | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^!QP#frt | LOCK|vZk | $33B | |||
| Viatris Inc
VTRS
| LOCK|^$QN>@? | LOCK|&& | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|x& | LOCK|&T | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|trq&&& | LOCK|^t< | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|SmGQy^@ | LOCK|SX@ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|vf&!<^z | LOCK|@gkyy | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|$^z#nBM | LOCK|#! | $2B |
United States